SARS-CoV-2 infection enhances vaccine-induced immunological memory against spike protein

Belgique Nouvelles Nouvelles

SARS-CoV-2 infection enhances vaccine-induced immunological memory against spike protein
Belgique Dernières Nouvelles,Belgique Actualités
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 80 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 71%

SARS-CoV-2 infection enhances vaccine-induced immunological memory against spike protein Coronavirus Disease COVID Protein SARSCoV2 SpikeProtein Vaccine ScienceTM UnivLyon1CNRS UniversiteLyon Inserm

By Pooja Toshniwal PahariaMar 22 2023Reviewed by Benedette Cuffari, M.Sc. In a recent study published in the journal Science Translational Medicine, researchers in France perform a longitudinal follow-up assessment of severe acute respiratory syndrome coronavirus 2 spike glycoprotein-specific immunological memory among unvaccinated and vaccinated coronavirus disease 2019 convalescents, as well as COVID-19-naïve vaccinees.

Evaluating immune responses induced by prior COVID-19 and subsequent vaccinations could improve the understanding of how this hybrid immunity contributes to immunological memory. Furthermore, this information could aid in identifying high-risk individuals to be prioritized for booster vaccinations against COVID-19.

The occurrence of breakthrough infections was monitored based on the rebound of SARS-CoV-2 S receptor-binding domain immunoglobulin G titers using SARS-CoV-2 IgG assays. The researchers also examined serological memory B lymphocyte parameters such as avidity, neutralization potential, and titers of antibodies against the S protein subunit 1 and S RBD proteins.

Flow cytometry was performed to analyze the anti-RBD memory B lymphocyte compartment. Anti-RBD memory B lymphocyte trafficking and expression patterns were assessed based on α4β1, α4β7, β1/β7 integrins, cutaneous lymphocyte antigen , C-C chemokine receptor -4,7, 9, and CD62L. Matrix analysis was performed to determine the correlation between cellular and serological anti-S memory B lymphocyte markers.

Median antibody titers, which are expressed as binding antibody unit /mL, among vaccinated COVID-19 convalescents for single BNT162b2 vaccination, double BNT162b2 vaccination, and single ChAdOx vaccination were 1,214, 1,193, and 851 BAU/mL, respectively. Similar findings were observed in the HAE model, irrespective of anti-RBD IgG titers. Anti-RBD antibodies had higher avidity among vaccinees than among unvaccinated COVID-19 convalescents, irrespective of prior COVID-19 history.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

NewsMedical /  🏆 19. in UK

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronavirusesIdentification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronavirusesA new class of antibody binding a highly conserved epitope on the spike S2 domain of MERS-CoV, SARS-CoV, and SARS-CoV-2 viruses is described.
Lire la suite »

Study suggests saliva samples may be better indicators of SARS-CoV-2 persistence than nasal swabsStudy suggests saliva samples may be better indicators of SARS-CoV-2 persistence than nasal swabsIn a recent study published in the PLOS ONE journal, researchers at Rutgers New Jersey Medical School explored the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human saliva.
Lire la suite »

Study provides insights on stability of SARS-CoV-2 in biological fluids of animalsStudy provides insights on stability of SARS-CoV-2 in biological fluids of animalsIn a recent study published in the Viruses journal, researchers assessed the stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among biological fluids found in animals.
Lire la suite »

Tetravalent COVID vaccine provides broad antibody responses against SARS-CoV-2 variants in animal modelTetravalent COVID vaccine provides broad antibody responses against SARS-CoV-2 variants in animal modelIn a recent study posted to the bioRxiv* preprint server, researchers in Italy and the United States evaluated the efficacy and immunogenicity of an adjuvanted tetravalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein subunit 1 (S1) COVID-19 vaccine.
Lire la suite »

Emergence and persistency of SARS-CoV-2 Omicron BA.2.3.7 in TaiwanEmergence and persistency of SARS-CoV-2 Omicron BA.2.3.7 in TaiwanEmergence and persistency of SARS-CoV-2 Omicron BA.2.3.7 in Taiwan Coronavirus Disease COVID Omicron SARSCoV2 BA237 Taiwan CDC_NCEZID
Lire la suite »

Elevated mucosal immune response expedites COVID-19 recoveryElevated mucosal immune response expedites COVID-19 recoveryElevated mucosal immune response expedites COVID-19 recovery Coronavirus Disease COVID ImmuneResponse Mucosal ResearchSquare KingsCollegeLon nih_nhlbi UniofOxford imperialcollege
Lire la suite »



Render Time: 2025-03-03 21:00:46